Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into the Structure and Function of the OTU Protease Virulence Factors from Emerging Human Nairoviruses.

ACS infectious diseases·2026
Same author

Intramolecular displacement reactions involving sulfur leading to the formation of 3,6-thiaanhydro sugar derivatives during the synthesis of 3,5-dithio-glucofuranose.

European journal of organic chemistry·2026
Same author

Site-Selective Distal Arylation of Sugars Enabled by Cyclic Acetals.

Journal of the American Chemical Society·2026
Same author

TIAL1 regulates the Hippo pathway through an RNA-binding-independent mechanism.

Oncogene·2026
Same author

Endocyclic Trisubstituted Hydroxylamine Isosteres of Basic Amines for ADME Modulation and Reduction of hERG Activity.

ACS medicinal chemistry letters·2026
Same author

Synthesis of 3‑<i>C</i>‑Methyl‑d‑Mannopyranoside Derivatives Functionalized at the 3‑Position.

ACS omega·2026

Related Experiment Video

Updated: Aug 7, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.4K

Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening.

Yifei Wu1, Scott D Pegan2, David Crich3

  • 1School of Electrical and Computer Engineering, College of Engineering, University of Georgia, Athens, GA 30602, USA.

International Journal of Molecular Sciences
|March 11, 2023
PubMed
Summary

Researchers screened over 26,000 compounds to find new COVID-19 drug candidates targeting the SARS-CoV-2 papain-like protease (PLpro). Promising compounds with strong binding affinities were identified for potential antiviral therapies.

Keywords:
COVID-19MD simulationsPL proteasedrug discoveryvirtual screening

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K

Related Experiment Videos

Last Updated: Aug 7, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.4K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K
Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K

Area of Science:

  • Drug Discovery
  • Computational Chemistry
  • Virology

Background:

  • Papain-like protease (PLpro) is essential for SARS-CoV-2 replication and pathogenesis.
  • Targeting viral proteases is a validated strategy for antiviral drug development.

Purpose of the Study:

  • To identify novel drug candidates targeting SARS-CoV-2 PLpro through virtual screening.
  • To evaluate the binding affinity and drug-likeness of identified compounds.

Main Methods:

  • Virtual screening of a 26,193 compound library against SARS-CoV-2 PLpro.
  • Molecular docking simulations to predict binding energies and interactions.
  • Analysis of ADME and drug-likeness properties.

Main Results:

  • Identified several drug candidates with high binding affinities to SARS-CoV-2 PLpro.
  • Top compounds exhibited superior estimated binding energy compared to previously reported candidates.
  • Computational predictions of critical interactions aligned with experimental biological data.

Conclusions:

  • The identified compounds represent promising leads for developing new COVID-19 therapeutics.
  • Virtual screening and computational methods are effective for discovering antiviral drug candidates.
  • Further experimental validation is warranted for the identified compounds.